MICROPULSED LASER PHOTOCOAGULATION AND INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTION FOR THE TREATMENT OF RETINAL ANGIOMATOUS PROLIFERATION

• DOI: 10.1097/iae.0b013e3180ed45a6
• Publication Date: 2009-03-05T02:44:36Z
• Authors: DANIEL B. ROTH; INGRID U. SCOTT; JONATHAN M. GLOTH; STUART N. GREEN; DAVID L. YARIAN; MATTHEW WHEATLEY
• Keywords: Acetonide

To investigate visual acuity and fluorescein angiographic outcomes, as well adverse events, associated with treatment of retinal angiomatous proliferation (RAP) micropulsed laser photocoagulation intravitreal triamcinolone acetonide injection.In this retrospective, noncomparative, interventional, consecutive case series, the medical records all patients treated for RAP (yellow or green dye; duration, 0.02-0.05 second; power adjusted to achieve a white burn moderate intensity at level lesion in retina) (4 mg/0.1 mL) injection between January 2003 November 2004 were reviewed by one four retina specialists single practice. Main outcome measures acuity, leakage shown angiography, events.The study included 14 eyes 13 (8 women 5 men; median age, 83 years [range, 70-90 years]). Triamcinolone preceded duration 7 days (range, 5-16 days) 8 eyes, was performed on same day 2 followed 7-28 4 eyes. Eyes 18 months 12-27 months) after both injection. Compared pretreatment vision 12 last follow-up examination stable (36%), improved >or=2 lines 6 (43%), worsened 3 (21%). The before 20/200 compared 20/80 (P = 0.02), 20/100 0.16), 0.73), 0.63) examination. For (93%), angiography administration demonstrated resolution leakage; eye photodynamic therapy verteporfin persistent low-grade leakage. Elevated intraocular pressure (>25 mm Hg) occurred 2.5 injection; transient use antiglaucoma eyedrops. Seven (78%) 9 phakic had cataract progression, these underwent extraction during period. No other events occurred.Micropulsed may be effective safe lesions.